FIELD: medicine.
SUBSTANCE: invention refers to medicine, and can be used in need of intradermal introduction of preparations. That is ensured by using the method involving the stages of applying a package of microneedles containing 10 to 30 hollow microneedles more than 100 mcm long to the patient's skin. The microneedle penetration depth is less than 1 mm. The average microneedle distance within the package makes not less than 1.5 mm in average. More than 200 mcl of the therapeutic agent is introduced through the hollow microneedles at a rate exceeding 20 mcl/min.
EFFECT: method provides the effective transdermal drug delivery in a combination with pain relieve ensured by using the specific parameters of the microneedles in the package.
12 cl, 6 tbl, 11 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
MICRONEEDLE, MOULD FOR PRODUCING SAME AND METHOD OF PRODUCING MICRONEEDLE | 2014 |
|
RU2679107C2 |
MICRONEEDLE ARRAYS AND METHODS FOR PRODUCING AND USING THEM | 2017 |
|
RU2750904C2 |
METHODS AND DEVICES FOR DRUG DELIVERY TO EYE TISSUE WITH MICRONEEDLE | 2011 |
|
RU2635320C2 |
DICLOFENAC GEL | 2007 |
|
RU2463038C2 |
ARRAY OF MICRONEEDLES MANUFACTURED BY INJECTION-COMPRESSION MOULDING AND METHOD OF MOULDING ARRAY OF MICRONEEDLES | 2011 |
|
RU2560646C9 |
TRANSDERMAL DELIVERY OF HIGH-BINDED BIOACTIVE AGENTS | 2012 |
|
RU2630610C2 |
MICRONEEDIC APPLICATOR AND METHOD OF ITS MANUFACTURE | 2016 |
|
RU2652567C1 |
MICROSTRUCTURE ARRAY FOR DELIVERY OF ACTIVE AGENTS | 2014 |
|
RU2662432C2 |
DEVICE FOR TRANSDERMAL DRUG DELIVERY | 2014 |
|
RU2622605C2 |
HOLLOW MICRONEEDLE MATRIX | 2010 |
|
RU2508135C2 |
Authors
Dates
2013-10-10—Published
2009-11-17—Filed